Calculate the CIWA-Ar score (Clinical Institute Withdrawal Assessment for Alcohol) to assess severity of alcohol withdrawal symptoms and guide treatment.
The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) Calculator is the gold-standard tool for assessing the severity of alcohol withdrawal syndrome. Used worldwide in emergency departments, detox units, and inpatient wards, the CIWA-Ar provides a 10-item scoring system that rates symptoms from nausea and tremor to hallucinations and disorientation, yielding a composite score from 0 to 67.
Alcohol withdrawal is a potentially life-threatening condition that occurs when a person with alcohol dependence suddenly reduces or stops drinking. Symptoms range from mild anxiety and tremors (6–12 hours after last drink) to seizures (12–48 hours) and delirium tremens (48–96 hours), which carries a 1–5% mortality rate without treatment. The CIWA-Ar enables clinicians to quantify withdrawal severity and determine whether pharmacological intervention (typically benzodiazepines such as chlordiazepoxide or lorazepam) is needed.
This calculator scores each of the 10 CIWA-Ar domains and provides the total score with severity classification, recommended management actions, and visual breakdowns of each component. Symptom-triggered therapy guided by CIWA-Ar scores has been shown to reduce total benzodiazepine use by 60% and shorten treatment duration compared to fixed-dose protocols.
Alcohol withdrawal can escalate rapidly from mild symptoms to life-threatening seizures and delirium tremens. The CIWA-Ar protocol enables standardized, objective assessment that guides symptom-triggered benzodiazepine therapy. This approach is endorsed by the American Society of Addiction Medicine (ASAM) and reduces over-sedation, shortens hospital stays, and improves patient outcomes compared to fixed-schedule dosing.
CIWA-Ar Total = Nausea (0–7) + Tremor (0–7) + Sweats (0–7) + Anxiety (0–7) + Agitation (0–7) + Tactile (0–7) + Auditory (0–7) + Visual (0–7) + Headache (0–7) + Orientation (0–4) Maximum Score: 67 Severity: • ≤ 8: Mild withdrawal • 9–15: Moderate withdrawal • 16–20: Severe withdrawal • > 20: Very severe (high risk of delirium tremens)
Result: CIWA-Ar Score: 20 — Severe Withdrawal
The total is 4+3+3+4+2+1+1+0+2+0 = 20. A score of 16–20 indicates severe withdrawal. Scheduled benzodiazepines and close monitoring with reassessment every 1–2 hours is recommended. At this level, the patient is at elevated risk for progression to seizures or delirium tremens.
Chronic alcohol use enhances GABA inhibition and suppresses NMDA excitatory signaling. When alcohol is withdrawn, the brain enters a hyperexcitable state with excessive glutamate activity and reduced GABAergic tone. This causes the spectrum of withdrawal symptoms: tremor, anxiety, autonomic instability, seizures, and potentially delirium tremens.
The standard protocol involves assessing CIWA-Ar every 1–2 hours during active withdrawal. For symptom-triggered therapy, benzodiazepines are administered when scores ≥ 8–10. Typical starting doses are chlordiazepoxide 25–50 mg or lorazepam 2 mg. Reassess 1 hour after each dose. Once CIWA-Ar remains < 8 for 24 hours, monitoring can be reduced to every 4–8 hours.
Factors that increase risk of severe withdrawal and delirium tremens include: history of previous DT or withdrawal seizures, heavy prolonged use, concurrent medical illness, advanced age, abnormal liver function, and high CIWA-Ar score on initial assessment (> 15). These patients may warrant prophylactic benzodiazepines and ICU-level monitoring regardless of initial CIWA-Ar scores.
The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) is a validated 10-item clinical tool that quantifies the severity of alcohol withdrawal on a scale of 0–67. It was developed by Sullivan et al. in 1989 and is the most widely used assessment for managing alcohol withdrawal in clinical settings.
CIWA-Ar should be administered upon admission for any patient at risk of alcohol withdrawal, then every 1–2 hours during active withdrawal. Once scores remain below 8 for 24 hours, monitoring frequency can be reduced. It should not be used in patients who are actively intoxicated.
Most protocols administer benzodiazepines when the CIWA-Ar score is ≥ 8–10. Typical dosing: chlordiazepoxide 25–100 mg or lorazepam 2–4 mg every 1–2 hours until CIWA-Ar < 8. The exact threshold varies by institution protocol.
Delirium tremens (DT) is the most severe form of alcohol withdrawal, occurring in 3–5% of withdrawal cases, usually 48–96 hours after the last drink. Symptoms include severe agitation, confusion, hallucinations, fever, tachycardia, and seizures. Untreated DT has a mortality rate of up to 37%, reduced to 1–5% with appropriate treatment.
No. CIWA-Ar is validated specifically for alcohol withdrawal. For benzodiazepine withdrawal, the CIWA-B (Clinical Institute Withdrawal Assessment for Benzodiazepines) or the BWS (Benzodiazepine Withdrawal Symptom Questionnaire) should be used instead.
Symptom-triggered therapy gives benzodiazepines only when CIWA-Ar scores exceed a threshold (typically ≥ 8–10). Fixed-dose therapy gives scheduled doses regardless of symptoms. Studies show symptom-triggered therapy results in 60% less medication, shorter treatment duration, and equivalent safety.